Mini/Micro LED is a new display technology, it has advantages of long-life, energy-saving, fast response speed and brightness. The mass transfer speed of Mini/Micro LED is main challenge for its large-scale application. Magnetic levitation platform with long stroke is vital to increase the mass transfer speed. The magnetic circuit is important to improve the stroke of the magnetic levitation platform. The existing magnetic circuit can't decrease the levitation power consumption for long stroke magnetic levitation platform and no evaluation metrics can be used to evaluate the magnetic circuit design. To improve the stroke of magnetic levitation platform, a novel Halbach PM array is proposed and optimized. The is first used to evaluate Halbach PM array. The novel Halbach PM is optimized with the , the L and the L is optimized. The result shows that the can be improved by increasing the L and decreasing the L. The passive MB force is increased to 37 N when the is 56.7 %. Finally, a novel Halbach permanent magnet array is manufactured and the MFD experiment is done. The result shows that MFD obtained by the three methods are essentially same.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11867281 | PMC |
http://dx.doi.org/10.1016/j.heliyon.2025.e42269 | DOI Listing |
J Heart Lung Transplant
March 2025
BrioHealth Solutions, Burlington, MA.
Background: Contemporary durable left ventricular assist devices (LVAD) have established current benchmarks for patient outcomes, but introduction of more novel technology is lacking. The BrioVAD System (BrioHealth Solutions, Burlington, MA) is an innovative, fully magnetically levitated pump intended to provide short-term (ST) and long-term (LT) mechanical circulatory support.
Methods: The Investigation of a Novel, MagNetically Levitated VAD for the Treatment of RefractOry Left Ventricular HeArT FailurE Clinical Trial (INNOVATE) is designed to evaluate safety and efficacy of the BrioVAD by demonstrating non-inferiority to the HeartMate 3 (HM3; Abbott Labs, Chicago, IL).
ASAIO J
March 2025
From the Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Outflow graft obstruction (OGO) is an under-reported but severe complication after insertion of magnetically levitated centrifugal-flow left ventricular assist devices (LVADs). The optimal treatment and long-term outcomes have not been well-described. We report a retrospective single high-volume center's experience with surgical exploration for OGO from June 2019 to October 2023.
View Article and Find Full Text PDFHeliyon
February 2025
Beijing Institute of Petrochemical Technology, Beijing, 102617, PR China.
Mini/Micro LED is a new display technology, it has advantages of long-life, energy-saving, fast response speed and brightness. The mass transfer speed of Mini/Micro LED is main challenge for its large-scale application. Magnetic levitation platform with long stroke is vital to increase the mass transfer speed.
View Article and Find Full Text PDFAdv Biol (Weinh)
February 2025
Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University, Stanford, CA, 94305, USA.
Dysfunction in adipose tissue can cause serious health problems, including obesity, type-2 diabetes, and cardiovascular disease, significantly reducing human life expectancy. Differences in differentiation and lipid accumulation in adipocytes reflect their functional status, making it important to characterize adipocytes by monitoring biophysical changes during adipogenic differentiation. However, there is currently no specific cell surface marker to separate mature adipocytes from non-adipose cells based on their lipid content, and separation of mature adipocytes is challenging due to handling limitations without fixation, antibody staining, or particle conjugation.
View Article and Find Full Text PDFiScience
February 2025
Heart Failure and Valve Surgery Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
The CH-VAD is a fully magnetically levitated left ventricular assist device (LVAD) designed for optimized hemocompatibility. This study evaluates the clinical outcomes of 77 patients implanted with the CH-VAD across seven centers in China from June 2022 to June 2024. Patients had a mean age of 57.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!